Skip to main content
INCORTEX · CMC PROCESS PLATFORM

Your CMC knowledge. Productized.

Process development assistant trained on Inscinstech's v2.2 CMC knowledge base, FDA review documents, and your own historical batches. 21 CFR Part 11-ready.

Free to start · upgrade any time
mAb-003 · Purification process · v0.3DoE-backed
CAPTURE
Protein A
MabSelect · pH 7.4 · DBC 50 g/L
load 42 g/L
POLISH
CEX
Capto S · pH 5.1 · NaCl 200 mM
DoE optimum
VIRAL
Low-pH hold
pH 3.5 · 30 min · + 20 nm filter
≥ 6 LRV
FINAL
UF/DF
Pellicon 3 · 30 kDa · Buffer A
50 mg/mL
Predicted CQAs
78%Yield
0.3%HMW
12 ppmHCP
≥6Viral LRV
✓ Audit trail✓ 21 CFR Part 11 signature ready
01 — THE PROBLEM

CMC knowledge is tribal — and that's the problem.

Every process scientist carries 10 years of habits, preferences, unwritten rules.

When they leave, that knowledge leaves with them. When a new molecule arrives, half the team relearns it.

What if the knowledge stayed?

02 — THE SOLUTION

A copilot trained on real CMC.

InCortex absorbs Inscinstech's CMC v2.2 knowledge base (82+ entries), FDA review docs, and your team's batch records — as a process design copilot.

03 — CAPABILITIES

Five workflows across the CMC lifecycle.

From the initial process tree to the final IND/NDA document draft.

P0 · CORE

Process development assistant

User describes the molecule + target; the Agent recommends a process across capture / polish / viral / final steps — with resin, buffer, parameter ranges, risk flags, and alternatives per step. Backed by a real chromatography-column catalog and multi-tenant process records.

TIER · Pro+
P1

DoE design · execution · analysis

Live DoE workspace backed by a Gaussian-process + active-learning microservice: factors / responses, response surface, and a recommended next run. Writes to an auditable process record.

TIER · Pro+
P2

Impurity attribution + method development

Upload HPLC / MS data; the Agent attributes impurity sources (OligoMS approach) and recommends characterization methods + limits.

TIER · Plus+
P3

Risk assessment + ICH Q9 automation

FMEA / Risk Assessment templates + AI fill, outputs IND/NDA report drafts.

TIER · Plus+
P4

CMC document drafting

Development report · Process description · Specification draft generation, FDA / NMPA style-matched.

TIER · Plus+
P5

Competitive & pipeline intelligence · scheduled digests

Track a related company’s development pipeline and summarize updates as they land; compile a weekly industry-trend digest. One of the scheduled-task types — runs in the background and delivers to you on cadence.

TIER · Free+
04 — COMPLIANCE

GxP-ready from day one.

We didn't add compliance as an afterthought. It's a primary engineering constraint.

✓21 CFR Part 11 compliant electronic records and signatures
✓Immutable audit trail (Temporal-backed long workflows)
✓Role-based access control (RBAC) per project, per stage
✓Customer data never trains the model (contractually guaranteed)
✓Private deployment available (on customer infrastructure)
✓IBS integration for accounts, billing, audit
✓No internet exfiltration in private deployment mode
05 — USE CASES

Three roles. Three force multipliers.

CM
CMC manager

“Turns the P-2 → P-3 transition from trial-and-error into a few evidence-backed DoE rounds.”

Internal process-dev pilot · target scenario
PS
Senior process scientist

“InCortex drafts the dev report; I spend my time on the decisions and the review.”

Internal process-dev pilot · target scenario
CR
CRO CMC lead

“A small team punches above its weight — InCortex keeps accumulated process know-how at hand.”

Internal process-dev pilot · target scenario
06 — SAMPLE OUTPUT

An InCortex process design.

app.inscinstech.ai
mAb-003 · Purification process · v0.3DoE-backed
CAPTURE
Protein A
MabSelect · pH 7.4 · DBC 50 g/L
load 42 g/L
POLISH
CEX
Capto S · pH 5.1 · NaCl 200 mM
DoE optimum
VIRAL
Low-pH hold
pH 3.5 · 30 min · + 20 nm filter
≥ 6 LRV
FINAL
UF/DF
Pellicon 3 · 30 kDa · Buffer A
50 mg/mL
Predicted CQAs
78%Yield
0.3%HMW
12 ppmHCP
≥6Viral LRV
✓ Audit trail✓ 21 CFR Part 11 signature ready
07 — FAQ

Common questions

In private mode, InCortex runs on your infrastructure (Kubernetes / VM). No telemetry. No external model calls unless you configure them. Audit logs stay on-prem.
No — it gives them leverage. Drafts come from InCortex; decisions, risk acceptance, and final sign-off come from your team. The audit trail records who approved what.
Inscinstech CMC v2.2 (82+ entries spanning capture, polishing, viral safety, filtration, formulation) plus a public corpus of FDA review documents. Your team's batch records layer on top — never shared.
Yes — IBS is supported natively (accounts / billing / audit). LIMS via standard API integration on Enterprise.
Want the full picture?Explore InCortex features

Stop relearning what you already know.

Start free — upgrade to Pro / Plus / Max any time.

Request accessTalk to a CMC consultant
InCortex · CMC process-development platform | inscinstech.ai